Back to search

Spain· ES:1201438002

ENERZAIR BREEZHALER 114 MICROGRAMOS/46 MICROGRAMOS/136 MICROGRAMOS POLVO PARA INHALACION (CAPSULA DURA)

A medicinal product containing indacaterol + glicopirronio + mometasona, registered in Spain by Novartis Europharm Limited.

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedENERZAIR BREEZHALER 114 MICROGRAMOS/4…ATC—REGISTER NO.ES:1201438002PACKS LISTED2CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
indacaterol + glicopirronio + mometasona
Manufacturer
Novartis Europharm Limited
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 2

2 priced
  • cima_codigo
    728965
    30
    EUR 72.68
  • cima_codigo
    728966
    30
    EUR 72.68

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/0762e51d-615f-4d07-b2c3-481df53c448c
GET /v1/drugs/0762e51d-615f-4d07-b2c3-481df53c448c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":1597010400000}",
  "nregistro": "1201438002",
  "substance": "indacaterol + glicopirronio + mometasona"
}

See everything about indacaterol + glicopirronio + mometasona.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.